Results 61 to 70 of about 20,218 (225)

Encorafenib‐associated acantholytic dermatosis in collision with eccrine squamous syringometaplasia

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Francisco Meraz‐Torres   +5 more
wiley   +1 more source

Early systemic intervention for vitiligo: A prospective bicentric interventional study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Patients with non‐segmental vitiligo were enrolled into three groups according to the duration and activity of their disease. All subjects received NB‐UVB phototherapy and an oral mini‐pulse of systemic corticosteroids twice weekly for 6 months. Early systemic treatment allows better repigmentation, including in difficult‐to‐treat areas.
Clemence Bertold   +8 more
wiley   +1 more source

Dermatologie et Endocrinologie. Du bon usage des corticoïdes en dermatologie clinique

open access: yes, 2016
Nous rapportons le contenu de la réunion PEAU’se dermatologique du 22 octobre 2015, organisée par le service de dermatologie des Cliniques universitaires Saint-Luc et consacrée aux pathologies dermatologiques et endocrinologiques. Le professeur D. Maiter
Colmant, Caroline   +4 more
core  

Chronic pruritus treated with alendronate in bilateral striopallidodentate calcinosis associated with an SLC20A2 gene mutation

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Adrien Boyard   +12 more
wiley   +1 more source

Immune‐related adverse events with mogamulizumab in cutaneous T‐cell lymphoma: A multicentre study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In a nationwide multicentre study of 403 patients with cutaneous T‐cell lymphoma treated with mogamulizumab, non‐MAR immune‐related adverse events were reported in 8.4% of patients across responding centres. These events were diverse, sometimes severe or persistent, and could occur late during mogamulizumab treatment.
David Neubauer   +28 more
wiley   +1 more source

Hidradentis suppurativa: Eine oft nicht erkannte Erkrankung

open access: yes, 2012
Universitätsklinik für ...
Hunger, Robert
core  

Innovations 2022 en dermatologie

open access: yes, 2023
L’arrivée des inhibiteurs de Janus-Kinase (JAKi) dans l’arsenal thérapeutique en dermatologie permet une évolution considérable de la prise en charge de certaines pathologies inflammatoires comme la dermatite atopique, ou les maladies auto-immunes comme ...
Baeck, Marie, De Greef, Axel
core  

Treatment of advanced cutaneous squamous cell carcinoma with cemiplimab in elderly multimorbid patients – a case series

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Patryk Porebski   +3 more
wiley   +1 more source

Illuminating Connections: Exploring the Dynamic Relationship Between Phototherapy and the Skin

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT The neonatal period represents a critical window for skin barrier maturation, microbial colonization, and immune development. As such, early‐life exposures may exert lasting effects on dermatologic and systemic health. A common early‐life exposure is blue light phototherapy (BLP), a life‐saving treatment for neonatal hyperbilirubinemia ...
Meshi Paz, Peter Lio
wiley   +1 more source

Digital transformation and the future of dermatology lectures in 2026 – results of a student survey in Leipzig

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Franziska Jochims   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy